These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 12874017

  • 1. CpG oligodeoxynucleotides enhance the capacity of adenovirus-mediated CD154 gene transfer to generate effective B-cell lymphoma vaccines.
    Rieger R, Kipps TJ.
    Cancer Res; 2003 Jul 15; 63(14):4128-35. PubMed ID: 12874017
    [Abstract] [Full Text] [Related]

  • 2. In vivo antitumor effect of CD40L-transduced tumor cells as a vaccine for B-cell lymphoma.
    Briones J, Timmerman J, Levy R.
    Cancer Res; 2002 Jun 01; 62(11):3195-9. PubMed ID: 12036933
    [Abstract] [Full Text] [Related]

  • 3. In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154.
    Loskog A, Tötterman TH, Böhle A, Brandau S.
    Cancer Gene Ther; 2002 Oct 01; 9(10):846-53. PubMed ID: 12224026
    [Abstract] [Full Text] [Related]

  • 4. 4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine.
    Guinn BA, DeBenedette MA, Watts TH, Berinstein NL.
    J Immunol; 1999 Apr 15; 162(8):5003-10. PubMed ID: 10202049
    [Abstract] [Full Text] [Related]

  • 5. Use of adenoviruses encoding CD40L or IL-2 against B cell lymphoma.
    Meziane el K, Bhattacharyya T, Armstrong AC, Qian C, Hawkins RE, Stern PL, Dermime S.
    Int J Cancer; 2004 Oct 10; 111(6):910-20. PubMed ID: 15300803
    [Abstract] [Full Text] [Related]

  • 6. CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma.
    Sandler AD, Chihara H, Kobayashi G, Zhu X, Miller MA, Scott DL, Krieg AM.
    Cancer Res; 2003 Jan 15; 63(2):394-9. PubMed ID: 12543793
    [Abstract] [Full Text] [Related]

  • 7. CpG-A and B oligodeoxynucleotides enhance the efficacy of antibody therapy by activating different effector cell populations.
    van Ojik HH, Bevaart L, Dahle CE, Bakker A, Jansen MJ, van Vugt MJ, van de Winkel JG, Weiner GJ.
    Cancer Res; 2003 Sep 01; 63(17):5595-600. PubMed ID: 14500400
    [Abstract] [Full Text] [Related]

  • 8. Transgenic expression of CD40L and interleukin-2 induces an autologous antitumor immune response in patients with non-Hodgkin's lymphoma.
    Takahashi S, Yotnda P, Rousseau RF, Mei Z, Smith S, Rill D, Younes A, Brenner MK.
    Cancer Gene Ther; 2001 May 01; 8(5):378-87. PubMed ID: 11477458
    [Abstract] [Full Text] [Related]

  • 9. Dendritic and tumor cell fusions transduced with adenovirus encoding CD40L eradicate B-cell lymphoma and induce a Th17-type response.
    Alvarez E, Moga E, Barquinero J, Sierra J, Briones J.
    Gene Ther; 2010 Apr 01; 17(4):469-77. PubMed ID: 20010627
    [Abstract] [Full Text] [Related]

  • 10. CpG-C ISS-ODN activation of blood-derived B cells from healthy and chronic immunodeficiency virus-infected macaques.
    Teleshova N, Kenney J, Williams V, Van Nest G, Marshall J, Lifson JD, Sivin I, Dufour J, Bohm R, Gettie A, Pope M.
    J Leukoc Biol; 2006 Feb 01; 79(2):257-67. PubMed ID: 16443827
    [Abstract] [Full Text] [Related]

  • 11. Enhancement of antigen-presenting ability of B lymphoma cells by immunostimulatory CpG-oligonucleotides and anti-CD40 antibody.
    Chen W, Yu Y, Shao C, Zhang M, Wang W, Zhang L, Cao X.
    Immunol Lett; 2001 May 01; 77(1):17-23. PubMed ID: 11348665
    [Abstract] [Full Text] [Related]

  • 12. Cytidine-phosphate-guanosine oligodeoxynucleotides and interferon-alpha-expressing tumor cells effectively induce dendritic cell maturation in vitro.
    Hiraide A, Hiroishi K, Ishii S, Eguchi J, Imawari M.
    Anticancer Res; 2006 May 01; 26(1A):211-8. PubMed ID: 16475701
    [Abstract] [Full Text] [Related]

  • 13. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
    Wang D, Molavi O, Lutsiak ME, Elamanchili P, Kwon GS, Samuel J.
    J Pharm Pharm Sci; 2007 May 01; 10(2):217-30. PubMed ID: 17706180
    [Abstract] [Full Text] [Related]

  • 14. Preventive and therapeutic antitumor effect of tumor vaccine composed of CpG ODN class C and irradiated tumor cells is triggered through the APCs and activation of CTLs.
    Novaković S, Stegel V, Kopitar A, Ihan A, Novaković BJ.
    Vaccine; 2007 Nov 28; 25(49):8241-56. PubMed ID: 17980936
    [Abstract] [Full Text] [Related]

  • 15. Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction.
    Hessel EM, Chu M, Lizcano JO, Chang B, Herman N, Kell SA, Wills-Karp M, Coffman RL.
    J Exp Med; 2005 Dec 05; 202(11):1563-73. PubMed ID: 16314434
    [Abstract] [Full Text] [Related]

  • 16. Long-term reversal of hypercholesterolemia in low density lipoprotein receptor (LDLR)-deficient mice by adenovirus-mediated LDLR gene transfer combined with CD154 blockade.
    Stein CS, Martins I, Davidson BL.
    J Gene Med; 2000 Dec 05; 2(1):41-51. PubMed ID: 10765504
    [Abstract] [Full Text] [Related]

  • 17. Immune stimulation by a CpG-containing oligodeoxynucleotide is enhanced when encapsulated and delivered in lipid particles.
    Mui B, Raney SG, Semple SC, Hope MJ.
    J Pharmacol Exp Ther; 2001 Sep 05; 298(3):1185-92. PubMed ID: 11504819
    [Abstract] [Full Text] [Related]

  • 18. Immunostimulatory oligodeoxynucleotides are potent enhancers of protective immunity in mice immunized with recombinant ORFF leishmanial antigen.
    Tewary P, Sukumaran B, Saxena S, Madhubala R.
    Vaccine; 2004 Aug 13; 22(23-24):3053-60. PubMed ID: 15297055
    [Abstract] [Full Text] [Related]

  • 19. CpG oligodeoxynucleotide-induced immunity prevents growth of germinal center-derived B lymphoma cells.
    Ponzio NM, Cutro S, Hu J, Marzouk A, Marshall JD.
    Int Immunopharmacol; 2006 Dec 20; 6(13-14):2057-68. PubMed ID: 17161362
    [Abstract] [Full Text] [Related]

  • 20. Gene transfer of noncleavable cell surface mutants of human CD154 induces the immune response and diminishes systemic inflammatory reactions.
    Masuta Y, Kato K, Tomihara K, Nakamura K, Sasaki K, Takahashi S, Hamada H.
    J Immunother; 2007 Oct 20; 30(7):694-704. PubMed ID: 17893562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.